SciELO - Scientific Electronic Library Online

 
vol.77 issue1Adalimumab, therapeutic alternative in the Vogt Koyanagi Harada syndrome refractory to infliximab: case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Anales de la Facultad de Medicina

Print version ISSN 1025-5583

Abstract

REVOREDO REGO, Fernando et al. Giant pancreatic insulinoma. An. Fac. med. [online]. 2016, vol.77, n.1, pp.59-64. ISSN 1025-5583.  http://dx.doi.org/10.15381/anales.v77i1.11555.

Insulinomas are the most common pancreatic neuroendocrine tumors and are typically small and benign. Giant pancreatic insulinomas are rare pancreatic tumors. We report a 67 year old man who presented with signs and symptoms of hypoglycemia. Subsequent laboratory and radiologic studies established the diagnosis of a 13.5 cm insulinoma. The patient underwent a pancreatoduodenectomy. Despite the size, neither local invasion nor metastatic disease was identified on pathological evaluation. In addition to describing the clinical presentation and operative findings, localization and management options of insulinomas are reviewed.

Keywords : Insulinoma, Giant; Pancreatic Neoplasms; Neuroendocrine Tumors.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )